Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects - No Study Results Posted

Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects (ASSIST)

This study has been completed.

Study NCT00707746 Information provided by Genzyme

First Received: June 27, 2008 Last Updated: March 14, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2011
Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: February 17, 2011